Abstract P3-10-06: Expression-Based Immune Signatures as Predictors of Neoadjuvant Targeted-/Chemo-Therapy Response: Experience From the I-Spy 2 TRIAL of ˜1000 Patients Across 10 Therapies

doi 10.1158/1538-7445.sabcs18-p3-10-06
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research

Related search

Credibility of 10/20 Experience as Compared With 5/10 Experience, by Roberts Lewis H.

ASTIN Bulletin
AccountingEconomicsEconometricsFinance
1962English

Chemotherapy Response and Recurrence-Free Survival in Neoadjuvant Breast Cancer Depends on Biomarker Profiles: Results From the I-Spy 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Breast Cancer Research and Treatment
Cancer ResearchOncology
2011English

An FDA Perspective on the Regulatory Implications of Complex Signatures to Predict Response to Targeted Therapies

Clinical Cancer Research
Cancer ResearchOncology
2016English

Clinical Experience of Dual Targeted Blockade (Pertuzumab + Trastuzumab + Docetaxel) in Neoadjuvant Therapy of Early HER-2-Positive Breast Cancer

Effective Pharmacotherapy
2019English

Serum Levels of Interleukin 10 (IL-10) in Patients With Type 2 Diabetes

Clinical Biochemistry
MedicineClinical Biochemistry
2011English

Immune Response to Intrathecal Enzyme Replacement Therapy in Mucopolysaccharidosis I Patients

Pediatric Research
Child HealthPediatricsPerinatology
2013English

Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience

Journal of Pediatrics
Child HealthPediatricsPerinatology
2018English

Parental Predictors of Children's Executive Functioning From Ages 6 to 10

British Journal of Developmental Psychology
DevelopmentalDevelopmental NeuroscienceEducational Psychology
2019English

National Indicators for Quality of Drug Therapy in Older Persons: The Swedish Experience From the First 10 Years

Drugs and Aging
GerontologyGeriatricsPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy